Paper33780951
Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies.
Chu PY and 3 others. Cells Tissues Organs, 2022. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies. Papers, record 33780951. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33780951
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chorioallantoic Membrane | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Chick Embryo | |
| Disease Models, Animal | |
| Heterografts | |
| Humans | |
| Neovascularization, Pathologic |
Source PubMed
References131
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19469865 | Overexpression of malignancy-associated laminins and laminin receptors by angiotropic human melanoma cells in a chick chorioallantoic membrane model. | J Cutan Pathol | 2009 | https://conductscience.org/library/papers/19469865 | PubMed |
| 2 | 2012235 | Morphometric measurements of chorioallantoic membrane vascularity: effects of hypoxia and hyperoxia. | Am J Physiol | 1991 | https://conductscience.org/library/papers/2012235 | PubMed |
| 3 | 27117272 | In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model. | J Otolaryngol Head Neck Surg | 2016 | https://conductscience.org/library/papers/27117272 | PubMed |
| 4 | 22019887 | Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. | Nat Med | 2011 | https://conductscience.org/library/papers/22019887 | PubMed |
| 5 | 20356949 | Effects of Monascus-fermented rice extract on malignant cell-associated neovascularization and intravasation determined using the chicken embryo chorioallantoic membrane model. | Integr Cancer Ther | 2010 | https://conductscience.org/library/papers/20356949 | PubMed |
| 7 | 16322244 | Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. | Cancer Res | 2005 | https://conductscience.org/library/papers/16322244 | PubMed |
| 8 | 12460930 | A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. | Cancer Res | 2002 | https://conductscience.org/library/papers/12460930 | PubMed |
| 9 | 29907679 | The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer. | EMBO Rep | 2018 | https://conductscience.org/library/papers/29907679 | PubMed |
| 10 | 30913539 | The avian chorioallantoic membrane as an alternative tool to study medullary thyroid cancer. | Endocr Connect | 2019 | https://conductscience.org/library/papers/30913539 | PubMed |
| 11 | 23666744 | Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. | EMBO Mol Med | 2013 | https://conductscience.org/library/papers/23666744 | PubMed |
| 12 | 28304379 | Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing. | Sci Rep | 2017 | https://conductscience.org/library/papers/28304379 | PubMed |
| 13 | 27703030 | The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer. | Sci Signal | 2016 | https://conductscience.org/library/papers/27703030 | PubMed |
| 14 | 7692142 | Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. | J Surg Res | 1993 | https://conductscience.org/library/papers/7692142 | PubMed |
| 15 | 2951264 | A chicken leukocyte common antigen: biochemical characterization and ontogenetic study. | Eur J Immunol | 1987 | https://conductscience.org/library/papers/2951264 | PubMed |
| 16 | 15020201 | Quantification of anti-angiogenesis using the capillaries of the chick chorioallantoic membrane demonstrates that the effect of human angiostatin is age-dependent. | Microvasc Res | 2004 | https://conductscience.org/library/papers/15020201 | PubMed |
| 17 | 15975046 | The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents. | Curr Cancer Drug Targets | 2005 | https://conductscience.org/library/papers/15975046 | PubMed |
| 18 | 11745087 | Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. | Anat Rec | 2001 | https://conductscience.org/library/papers/11745087 | PubMed |
| 19 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 20 | 28990079 | Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation. | Mol Med Rep | 2017 | https://conductscience.org/library/papers/28990079 | PubMed |
| 21 | 27723025 | Model of human recurrent respiratory papilloma on chicken embryo chorioallantoic membrane for tumor angiogenesis research. | Histol Histopathol | 2017 | https://conductscience.org/library/papers/27723025 | PubMed |
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42879029 | Chorioallantoic Membrane Assay to Assess Primary and Metastatic Tumor Growth in Ewing Sarcoma. | Methods Mol Biol | 2027 | https://conductscience.org/library/papers/42879029 | PubMed |
| 42639554 | Beta-cyclodextrin-based polymerized nanocarriers for doxorubicin delivery to cancer cells. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/42639554 | PubMed |
| 42511989 | Dual-Tracer Autoradiography and Positron Emission Tomography (PET) Scans Using In-Yolk-Sac Tracer Delivery in the Chicken Chorioallantoic Membrane (CAM) Tumor Model. | Biomedicines | 2026 | https://conductscience.org/library/papers/42511989 | PubMed |
| 42420312 | Spatial transcriptomic profiling of ovarian clear cell carcinoma reveals heterogeneity in OXPHOS and EMT gradients. | Nat Commun | 2026 | https://conductscience.org/library/papers/42420312 | PubMed |
| 42242475 | Characterizing ex vivo models for studying lipid metabolism in triple negative breast cancer. | J Lipid Res | 2026 | https://conductscience.org/library/papers/42242475 | PubMed |
| 42042116 | Comparative Evaluation of a Nanocellulose Hydrogel and Matrigel® in a Vascularized Intestinal-CAM Model. | Gels | 2026 | https://conductscience.org/library/papers/42042116 | PubMed |
| 42034658 | In ovo versus ex ovo incubation differentially shapes chorioallantoic membrane maturation, angiogenesis, and tumor growth. | Sci Rep | 2026 | https://conductscience.org/library/papers/42034658 | PubMed |
| 41901344 | Myricetin Inhibits Osteosarcoma Cell Viability and Modulates EMT-Related Genes Associated with the SNAI1/MMP-9 Axis. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901344 | PubMed |
| 41888798 | Beyond the mouse: 3R-guided alternative animal models transforming cancer research. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41888798 | PubMed |
| 41769258 | In Ovo CAM-Based Xenograft Model for Investigating Tumor Developmental Biology in Breast Cancer. | Bio Protoc | 2026 | https://conductscience.org/library/papers/41769258 | PubMed |
| 41744372 | Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo model. | Endocr Relat Cancer | 2026 | https://conductscience.org/library/papers/41744372 | PubMed |
| 41731278 | Imaging vascular characteristics and glycolytic metabolism of glioblastoma in a chick embryo model using 1H MRI and [18F]FDG-PET. | Mol Imaging Biol | 2026 | https://conductscience.org/library/papers/41731278 | PubMed |
| 41687260 | Single-cell transcriptomics of chicken ovarian cancer identifying immune subsets with prognostic implications. | Poult Sci | 2026 | https://conductscience.org/library/papers/41687260 | PubMed |
| 41599159 | Effect of Treatment with a Combination of Dichloroacetate and Valproic Acid on Adult Glioblastoma Patient-Derived Primary Cells Xenografts on the Chick Embryo Chorioallantoic Membrane. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41599159 | PubMed |
| 41598289 | The Chick Embryo Chorioallantoic Membrane Assay as a Short-Term Exploratory Model for Cervical Cancer Research. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41598289 | PubMed |
| 41303362 | Beyond Rodents: Alternative Animal Models in Colorectal Cancer Research. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303362 | PubMed |
| 41181421 | The chicken chorioallantoic membrane model for human surgeries and implants. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/41181421 | PubMed |
| 40594871 | Exploring the synergistic effects of metformin and doxorubicin loaded chitosan nanoparticles for A549 lung cancer therapy. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594871 | PubMed |
| 40548062 | Patient-derived xenograft models: Current status, challenges, and innovations in cancer research. | Genes Dis | 2025 | https://conductscience.org/library/papers/40548062 | PubMed |
| 40443053 | Dose-dependent induction of epithelial-mesenchymal transition in 3D melanoma models by non-thermal plasma treatment. | Mol Oncol | 2025 | https://conductscience.org/library/papers/40443053 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33780951
GET https://conductscience.org/api/papers/v1/33780951/references?page=2